Angiographically-Derived SYNTAX Score and Its Prognostic Value in Dialysis Patients: Comparison With the Khan Index

Canadian Journal of Cardiology

Volumn 28, Issue 4, 2012, Pages 450-457

  Tomaszuk Kazberuk, Anna ^a   Kozuch, Marcin ^a   Malyszko, Jolanta ^a   Bachorzewska Gajewska, Hanna ^a   Kobus, Grazyna ^a   Dobrzycki, Slawomir ^a   Musial, Wlodzimierz J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ASSESSMENT TOOL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; KHAN INDEX; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SURVIVAL; SYNTAX SCORE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CINEANGIOGRAPHY; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETIC NEPHROPATHIES; DRUG-ELUTING STENTS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; PACLITAXEL; PERITONEAL DIALYSIS; POLAND; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK FACTORS; ROC CURVE; SOFTWARE;

EID: 84863868208     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.01.007     Document Type: Article

References (30)

1. Capodanno D., Tamburino C. Integrating the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions. Am Heart J 2011, 161:462-470.
2. Park D.W., Kim Y.H., Yun S.C., et al. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting. J Am Coll Cardiol 2011, 57:2152-2159.
3. Garg S., Sarno G., Girasis C., et al. A patient-level pooled analysis assessing the impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 2011, 4:645-653.
4. He J.Q., Gao Y.C., Yu X.P., et al. Syntax score predicts clinical outcome in patients with three-vessel coronary artery disease undergoing percutaneous coronary intervention. Chin Med J (Engl) 2011, 124:704-709.
5. Chakravarty T., Buch M.H., Naik H., et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected LMCA revascularization. Am J Cardiol 2011, 107:360-366.
6. Palmerini T., Genereux P., Caixeta A., et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2011, 14:2389-2397.
7. Magro M., Nauta S., Simsek C., et al. Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAX score study. Am Heart J 2011, 161:771-781.
8. Garg S., Serruys P.W., Silber S., et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE all comers trial. JACC Cardiovasc Interv 2011, 4:432-441.
9. Ibrahim T.H., Mehmet E., Turgay I., Mustafa K., Ahmet K., Serdar S. Reproducibility of SYNTAX score: from core lab to real world. J Interv Cardiol 2011, 24:302-306.
10. Herzog C.A. Kidney disease in cardiology. Nephrol Dial Transplant 2007, 22:43-46.
11. Lang R.M., Bierig M., Devereux R.B., et al. Recommendation for the chamber quantification. Eur J Echocardiography 2006, 7:79-108. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology.
12. Khan I.H., Catto G.R., Edward N., Fleming L.W., Henderson I.S., MacLeod A.M. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993, 341:415-418.
13. Judkins M.P. Selective coronary arteriography. I. A percutaneous transfemoral technic. Radiology 1967, 89:815-824.
14. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000, 101:125-130.
15. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998, 97:2302-2306.
16. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996, 93:879-888.
17. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
18. SYNTAX score calculator [online calculator, launched 2009] SYNTAX Working Group, Accessed June 23, 2010. http://www.syntaxscore.com.
19. Postorino M., Marino C., Tripepi G., Zoccali C. Prognostic value of the New York Heart Association classification in end-stage renal disease. Calabrian Registry of Dialysis and Transplantation. Nephrol Dial Transplant 2007, 22:1377-1382.
20. Peterson E.D., Dai D., DeLong E.R., et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol 2010, 55:1923-1932. NCDR Registry Participants.
21. Romagnoli E., Burzotta F., Trani C., et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 2009, 95:43-48.
22. Wykrzykowska J.J., Garg S., Girasis C., et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted From A Durable Versus Erodable Stent Coating) trial. J Am Coll Cardiol 2010, 56:272-277.
23. Morice M.C., Serruys P.W., Kappetein A.P., et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial. Circulation 2010, 121:2645-2653.
24. Wykrzykowska J.J., Garg S., Onuma Y., et al. Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. EuroIntervention 2011, 7:605-613.
25. Serruys P.W., Onuma Y., Garg S., et al. 5-year clinical outcomes of the ARTS Series II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010, 55:1093-1101.
26. Kim Y.-H., Park D.-W., Kim W.-J., et al. Validation of SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. J Am Coll Cardiol Intv 2010, 3:612-623.
27. Serruys P.W., Onuma Y., Garg S., et al. Assessment of the SYNTAX score in the SYNTAX study. EuroIntervention 2009, 5:50-56.
28. Yan L.Q., Guo L.J., Zhang F.C., Gao W. The relationship between kidney function and angiographically-derived SYNTAX score [published online ahead of print July 24, 2011]. Can J Cardiol 2011, 7:768-772. org/. 10.1016/j.cjca.2011.04.004.
29. Coskun U., Orta Kilickesmez K., Abaci O., et al. The relationship between chronic kidney disease and SYNTAX score. Angiology 2011, 62:504-508.
30. Brener S.J., Prasad A.J., Abdula R., Sacchi T.J. Relationship between the angiographically derived SYNTAX score and outcomes in high-risk patients undergoing percutaneous coronary intervention. J Invasive Cardiol 2011, 23:66-69.